Latisse® is not a gimmick. It has been available for well over a decade (13 years!). During its time on the market Latisse® has participated in over 32 clinical trials with nearly 6,000 patients.
The active ingredient in Latisse®, bimatoprost, lengthens the growth phase of the eyelash hair follicle. The results are longer and thicker lashes.
Latisse® wastes no time in showing what it can do. Many patients begin to see results in under 8 weeks, reaching the full growth potential by 16 weeks.
Latisse® is the Only FDA Approved Eyelash Enhancing Product
Latisse® has undergone numerous and extensive clinical trials, proving itself to be effective and safe. Very few side effects are experienced in only a small percentage of users.
The ingredient in Latisse is commonly used in glaucoma eye drops.
Optometrists were finding that many of their glaucoma patients were telling them their eyelashes are getting longer and fuller. The company making the glaucoma drops then starting testing this ingredient specifically on the eyelashes and found out it really does enhance eyelash growth.
Latisse is a clinically tested prescription eyelash enhancer.
A disposable applicator brush is supplied and used to apply Latisse® once per day to the base of the upper eyelid.
Most patients will begin to notice the results of their Latisse® treatment after approximately eight weeks, with maximum impact over sixteen weeks.
No, they are not. Latisse® enhances the growth cycle of our eyelash follicles. As our eyelashes naturally fall out, and are replaced with new growth over a period of time, Latisse® must be continually used in order to maintain the new length and thickness.
A small percentage of clinical trial participants noted minor side effects.
These side effects include: